期刊文献+

Risedronate Inhibition of Matrix Metalloproteinase-2 Expression in Osteosarcoma Cell Line

Risedronate Inhibition of Matrix Metalloproteinase-2 Expression in Osteosarcoma Cell Line
暂未订购
导出
摘要 Background and objective Osteosarcoma is a high-malignant bone tumor and is the most frequent malignant bone tumor in children and adolescents. Significant proportions of the Background and objective Osteosarcoma is a high-malignant bone tumor and is the most frequent malignant bone tumor in children and adolescents. Significant proportions of the patient eventually develop pulmonary metastases and succumb to their disease even after conventional multi-agent chemotherapy and surgical excision. Several solid tumors display enhanced expression of matrix metalloproteinases (MMPs), and recently MMP- inhibitors have entered clinical trials. Bisphosphonate (BPs) have a profound effect on bone resorption and are widely used in treatment of osteoclast-mediated bone diseases and have been known to inhibit tumor growth and metastasis in some tumors such as breast cancer, renal cell carcinoma, and prostate cancer. The purpose of this study was to investigate the effect of the bisphosphonate on osteosarcoma cell invasion.
出处 《中国肺癌杂志》 CAS 2009年第6期664-665,共2页 Chinese Journal of Lung Cancer
关键词 肺癌 恶性肿瘤 炎症 Β-七叶皂甙钠 Osteosarcoma Bisphosphonate MMP-2
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部